{ "items": [ "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.\n

\n \n \n \n \n\n \n \n \n

Ndhlovu ZM. et al, (2015), Immunity, 43, 591 - 604

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals.\n

\n \n \n \n \n\n \n \n \n

Hoehn KB. et al, (2015), Philos Trans R Soc Lond B Biol Sci, 370

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n IVA: accurate de novo assembly of RNA virus genomes.\n

\n \n \n \n \n\n \n \n \n

Hunt M. et al, (2015), Bioinformatics, 31, 2374 - 2376

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n HLA-B*58:02-specific benefit of MRKAd5 Gag/Pol/Nef vaccine in an African population\n

\n \n \n \n \n\n \n \n \n

Leitman EM. et al, (2015), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 18

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Disease progression despite protective HLA expression in an HIV-infected transmission pair.\n

\n \n \n \n \n\n \n \n \n

Brener J. et al, (2015), Retrovirology, 12

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Disease progression despite protective HLA expression in an HIV-infected transmission pair\n

\n \n \n \n \n\n \n \n \n

Brener J. et al, (2015), Retrovirology

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n HLA-B*35:05 is a protective allele with a unique structure among HIV-1 CRF01_AE-infected Thais, in whom the B*57 frequency is low (vol 28, pg 959, 2014)\n

\n \n \n \n \n\n \n \n \n

Mori M. et al, (2015), AIDS, 29, 1275 - 1275

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n CD8+ TCR Bias and Immunodominance in HIV-1 Infection.\n

\n \n \n \n \n\n \n \n \n

Kl\u00f8verpris HN. et al, (2015), J Immunol, 194, 5329 - 5345

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.\n

\n \n \n \n \n\n \n \n \n

Adland E. et al, (2015), PLoS Pathog, 11

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Reply to Jefferys: Declining HIV virulence.\n

\n \n \n \n \n\n \n \n \n

Payne R. et al, (2015), Proc Natl Acad Sci U S A, 112

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Human parvovirus 4 infection among mothers and children in South Africa.\n

\n \n \n \n \n\n \n \n \n

Matthews PC. et al, (2015), Emerg Infect Dis, 21, 713 - 715

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.\n

\n \n \n \n \n\n \n \n \n

Kl\u00f8verpris HN. et al, (2015), Retrovirology, 12

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Reply to eisenhut.\n

\n \n \n \n \n\n \n \n \n

Muenchhoff M. and Goulder P., (2015), J Infect Dis, 211, 664 - 665

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Structured observations reveal slow HIV-1 CTL escape.\n

\n \n \n \n \n\n \n \n \n

Roberts HE. et al, (2015), PLoS Genet, 11

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Correction to \"Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection\" [J Virol. 2009, 83(19):10234-10244]\n

\n \n \n \n \n\n \n \n \n

Thobakgale CF. et al, (2015), Journal of Virology, 89

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Erratum: HLA-B\u221735:05 is a protective allele with a unique structure among HIV-1 CRF01-AE-infected Thais, in whom the B\u221757 frequency is low (AIDS (2014) 28 (959-967))\n

\n \n \n \n \n\n \n \n \n

Mori M. et al, (2015), AIDS, 29

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era.\n

\n \n \n \n \n\n \n \n \n

Adland E. et al, (2015), Front Microbiol, 6

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana.\n

\n \n \n \n \n\n \n \n \n

Matthews PC. et al, (2015), PLoS One, 10

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Role of HLA Adaptation in HIV Evolution.\n

\n \n \n \n \n\n \n \n \n

Kl\u00f8verpris HN. et al, (2015), Front Immunol, 6

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.\n

\n \n \n \n \n\n \n \n \n

Mori M. et al, (2015), PLoS One, 10

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n" ], "more": "\n\n \n \n Load More\n \n \n\n", "msg": "" }